Okładka

Association between proton pump inhibitors and periodontal disease severity

Abstract Objectives Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid‐related gastrointestinal disorders. PPIs modulate osteoclast function, reduce gastric acid secretion, and are associated with the establishment of a more diverse gastrointestinal microbiota. Periodon...

Szczegółowa specyfikacja

Zapisane w:

Opis bibliograficzny
Główni autorzy:	Bhavneet K. Chawla (Autor), Robert E. Cohen (Autor), Lisa M. Yerke (Autor)
Format:	Książka
Wydane:	Wiley, 2022-02-01T00:00:00Z.
Hasła przedmiotowe:	article
Dostęp online:	Connect to this object online.
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

The influence of proton pump inhibitors on tissue attachment around teeth and dental implants: A scoping review
od: Bhavneet K. Chawla, i wsp.
Wydane: (2022)

Proton-pump inhibitors and risk of renal disease
od: Mahrang Hedaiaty, i wsp.
Wydane: (2017)

Is hypomagnesemia associated with using proton pump inhibitors?
od: Joo-Hark Yi, i wsp.
Wydane: (2016)

Proton-pump inhibitor use amongst patients with severe hypomagnesemia
od: Sherry Seah, i wsp.
Wydane: (2023)

RENAL SAFETY OF PROTON PUMP INHIBITORS
od: A. I. Dyadyk, i wsp.
Wydane: (2017)

The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
od: Dania Tawam, i wsp.
Wydane: (2021)

Association between Proton Pump Inhibitor Use and Parkinson's Disease in a Korean Population
od: Ji-Hee Kim, i wsp.
Wydane: (2022)

Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases
od: Laura Räisänen, i wsp.
Wydane: (2023)

Proton pump inhibitors in pediatric practice
od: Anna A. Shilova, i wsp.
Wydane: (2023)

Proton Pump Inhibitors and Gastric Cancer
od: Seungkyung Kang, i wsp.
Wydane: (2021)

The Association Between Prolonged Proton Pump Inhibitors Use and Bone Mineral Density
od: Fattahi MR, i wsp.
Wydane: (2019)

Proton Pump Inhibitors in the COVID-19 Pandemic
od: T. E. Kugler, i wsp.
Wydane: (2022)

Proton pump inhibitors usage and the risk of cancer
od: Hubert Wróblewski, i wsp.
Wydane: (2021)

Management of laryngopharyngeal reflux with proton pump inhibitors
od: Christina Reimer, i wsp.
Wydane: (2008)

Association Between Proton Pump Inhibitors and Asthma: A Population-Based Cohort Study
od: Yao-Tung Wang, i wsp.
Wydane: (2020)

Exploring and understanding adverse effect of Proton Pump Inhibitors
od: Hoque Majedul M.
Wydane: (2024)

Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease
od: Nam-Jun Cho, i wsp.
Wydane: (2018)

A Case of Severe Iron Deficiency Anemia Associated with Long-Term Proton Pump Inhibitor Use
od: David N. Dado, DO, i wsp.
Wydane: (2017)

Proton pump inhibitors overuse - consequences among patients
od: Patrycja Kmiotek, i wsp.
Wydane: (2019)

Proton pump inhibitors overuse - consequences among patients
od: Patrycja Kmiotek, i wsp.
Wydane: (2019)

The consequences of long-term therapy with proton pump inhibitors
od: Zuzanna Drygała, i wsp.
Wydane: (2024)

Proton Pump Inhibitors and Cancer: Current State of Play
od: Marie Bridoux, i wsp.
Wydane: (2022)

Can Proton Pump Inhibitors Affect Eradication Therapy?
od: Sung Eun Kim
Wydane: (2020)

Proton Pump Inhibitor Long-term Prescription, Is It Safe?
od: Tae Ho Kim
Wydane: (2020)

Proton pump inhibitor deprescription: A rapid review
od: Renata Rodriguez Imparato, i wsp.
Wydane: (2022)

The Impact of Sex on the Response to Proton Pump Inhibitor Treatment
od: Holmfridur Helgadottir, i wsp.
Wydane: (2023)

An unusual case of proton pump inhibitor induced hyperchromograninemia
od: Kwabena Oware Adu-Gyamfi, i wsp.
Wydane: (2019)

Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study
od: Yen-Chun Peng, i wsp.
Wydane: (2018)

The Role of Proton Pump Inhibitors in the Management of Pediatric Eosinophilic Esophagitis
od: Carolina Gutiérrez-Junquera, i wsp.
Wydane: (2018)

Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?
od: Rohit Tayal, i wsp.
Wydane: (2023)

Clinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors
od: Tae Jun Kim, i wsp.
Wydane: (2020)

Depression Events Associated with Proton-Pump Inhibitors in Postmarketing Drug Surveillance Data
od: Tigran Makunts, i wsp.
Wydane: (2023)

Proton Pump Inhibitors in IPF: A Call for Clinical Trials
od: Yohannes T. Ghebre, i wsp.
Wydane: (2018)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
od: Eugene Lin, i wsp.
Wydane: (2010)

Risk of Bacterial Infection from Proton Pump Inhibitor Use
od: Sung Soo Kim, i wsp.
Wydane: (2017)

Can proton pump inhibitors cause intestinal inflammation in children?
od: Ben Kang
Wydane: (2019)

The Effect of Proton Pump Inhibitors on Fracture Formation and Reflection on Care
od: Seda Akutay, i wsp.
Wydane: (2021)

Proton pump inhibitors to control phosphorus levels in hemodialysis patients
od: Amineh Hojati
Wydane: (2025)

Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19
od: Zhang XY, i wsp.
Wydane: (2021)

Irrational proton pump inhibitor use during corticosteroid therapy
od: Rakesh Agarwal, i wsp.
Wydane: (2018)